Entry Instance

HTTP 200 OK
Allow: GET, PUT, PATCH, DELETE, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "id": 1581425,
    "url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1581425/?format=api",
    "text_counter": 74,
    "type": "speech",
    "speaker_name": "Dagoretti North, ODM",
    "speaker_title": "Hon. Beatrice Elachi",
    "speaker": null,
    "content": " The World Health Organisation (WHO) reported increased cases of diabetes in the country in 2024, with a significantly low treatment coverage at fewer than four out of 10 diabetic adults receiving glucose-lowering medication. This low coverage has contributed to the high cost of treatment that averages at Ksh750 per insulin injection. That has resulted in low uptake of medication especially in low- income households. The prevalence of the disease has also been attributed to lack of screening due to limited awareness and availability of diagnostic and monitoring tests. The surge in diabetes and the high cost of accessing medication pose an imminent danger to the healthcare system and is likely to increase mortality rates in the country, if not addressed urgently. It is against this background that I request for a statement from the Chairperson of the Departmental Committee on Health on the following: 1. A detailed report on the measures being put in place by the Government to reduce the high prevalence of diabetes in the country, including subsidising the cost of treatment. 2. The measures that are being taken to raise awareness and encourage screening among Kenyans, including households in rural and marginalised areas of the country 3. Clarification on whether diabetes treatment is covered under the Social Health Insurance Fund (SHIF). If not, the measures that are being taken by the Government to ensure the provision of diabetes treatment under SHIF. I, thank you, Hon. Speaker."
}